Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

OptimizeRx (OPRX) Return on Capital Employed: 2011-2024

Historic Return on Capital Employed for OptimizeRx (OPRX) over the last 14 years, with FY2024 value amounting to 0.09%.

  • OptimizeRx's Return on Capital Employed rose 500.0% to 0.01% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.01%, marking a year-over-year increase of 500.0%. This contributed to the annual value of 0.09% for FY2024, which is 1000.0% up from last year.
  • As of FY2024, OptimizeRx's Return on Capital Employed stood at 0.09%, which was up 1000.0% from 0.19% recorded in FY2023.
  • OptimizeRx's 5-year Return on Capital Employed high stood at 0.0% for FY2021, and its period low was 0.19% during FY2023.
  • In the last 5 years, OptimizeRx's Return on Capital Employed had a median value of 0.09% in 2024 and averaged 0.08%.
  • As far as peak fluctuations go, OptimizeRx's Return on Capital Employed tumbled by -1000bps in 2022, and later surged by 1000bps in 2024.
  • OptimizeRx's Return on Capital Employed (Annual) stood at 0.04% in 2020, then surged by 109bps to 0.0% in 2021, then tumbled by -2501bps to 0.09% in 2022, then crashed by -97bps to 0.19% in 2023, then soared by 54bps to 0.09% in 2024.
  • Its Return on Capital Employed was 0.09% in FY2024, compared to 0.19% in FY2023 and 0.09% in FY2022.